Journal of Surgical Education
Volume 64, Issue 3 , Pages 158-161 , May 2007

Chronic Pancreatitis with Synchronous and Metachronous Malignancy: Three Unusual Cases and a Literature Review

References 

  1. Cooperman A. Surgery and chronic pancreatitis. Surgical Clin N Amer. 2001;81:431–457
  2. DiMola F, Friess H, Martignoni GM. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg. 1999;230:63–71
  3. Nealon WH, Thompson JC. Progressive loss of pancreatic function in chronic pancreatitis is delayed by main pancreatic duct decompression: a longitudinal prospective analysis of the modified Puestow procedure. Ann Surg. 1993;217:458–468
  4. Patel AG, Reber P, Toyama M, Ashley SW, Reber HA. Effect of pancreaticojejunostomy on fibrosis, pancreatic blood flow and interstitial pH in chronic pancreatitis. Ann Surg. 1999;230:672–679
  5. Luttges J, Kloppel G. Precancerous conditions of pancreatic carcinoma. J Hepatobiliary Pancreat Surg. 2000;7:568–574
  6. Sommers SC, Murphy SA, Warren S. Pancreatic duct hyperplasia and cancer. Gastroenterology. 1954;27:629–640
  7. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996;110:227–231
  8. Rivera JA, Rall CJ, Graeme-Cook F, et al. Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia. Surgery. 1997;121(1):42–49
  9. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer. 1979;43:1418–1428
  10. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol. 2000;156:2123–2133

PII: S1931-7204(06)00189-9

doi: 10.1016/j.jsurg.2006.11.006

Journal of Surgical Education
Volume 64, Issue 3 , Pages 158-161 , May 2007

Article Tools